About this page
RLAY — Relay Therapeutics
Why Relay Therapeutics (RLAY) moved: the last session's move split into the market, its industry, its themes and the part unique to the company, with our latest explained moves and their sources, beside the live chart.
On Friday, November 20, 2026, Relay Therapeutics (RLAY) rose 1.32% at the close. Where it came from: Market (SPY) -6.17%, Biotechnology +1.44%, Factors (6) +1.66%, Unique to RLAY +4.39%. Most of RLAY's gain was unique to the stock; the market detracted.
Relay Therapeutics (RLAY) last reported earnings on Wednesday, November 4, 2026, after the close (SEC 8-K); the next session, Thursday, November 5, 2026, RLAY fell 5.71% at the close. Its next report is estimated for about Friday, February 5, 2027 (between February 3 and February 7), after the close, from its own rhythm across 9 reports; not yet announced. The earnings calendar.
Explained moves for RLAY:
- Friday, November 20, 2026: RLAY rose 1.3% on the day JPMorgan named it a top biotech pick, per analyst commentary (investing.com)
Each explained move has its own page: Friday, November 20, 2026.
Only on this page: RLAY's split updating every minute while the market is open, which of the 6 factors moved it and by how much, and the catalyst behind its explained move, with sources.
Explore daily moves on this page shows where RLAY's moves came from, session by session — the market, its industry, its themes, its factors and its own part. The month and three-month views are free; six months, the year to date and the full year, with every day's breakdown and its full explanation, are part of TickerTiles Plus.
All stocks: Why stocks moved. The whole market: Market Overview.